Lymphoma, Large-Cell Completed Phase 1 / 2 Trials for Veltuzumab (DB05656)

Also known as: Large-cell Lymphoma

IndicationStatusPhase
DBCOND0030182 (Lymphoma, Large-Cell)Completed1 / 2
clinicaltrials.gov IdentifierTitlePurposeDrugs
NCT00546793Ph I/II Study of Subcutaneously Administered Veltuzumab (hA20) in NHL and CLLTreatment